62023TO0228_INF
Order of the President of the General Court of 19 July 2023 –Zaklady Farmaceutyczne Polpharma v Commission
(Case T‑228/23 R)
(Interim relief – Medicinal products for human use – Marketing authorisation – Application for interim measures – Application for injunction – Lack of urgency)
1.
Interim relief – Suspension of operation of a measure – Interim measures – Conditions for granting – Prima facie case – Urgency – Serious and irreparable damage – Cumulative nature – Balancing of all the interests involved – Order of examination and method of verification – Discretion of the court hearing the application for interim relief
(Arts 256(1), 278 and 279 TFEU; Rules of Procedure of the General Court, Art. 156(4))
(see paragraphs 20-23)
2.
Interim relief – Suspension of operation of a measure – Interim measures – Conditions for granting – Urgency – Serious and irreparable damage – Burden of proof borne by the party seeking the interim measure
(Arts 278 and 279 TFEU; Rules of Procedure of the General Court, Art. 156(4))
(see paragraph 26)
3.
Interim relief – Suspension of operation of a measure – Interim measures – Conditions for granting – Urgency – Serious and irreparable damage –Letter from the Commission requesting the applicant company to comply with the market protection period for a medicinal product being placed on the market by another company – No evidence of damage – Lack of urgency
(Arts 278 and 279 TFEU; Rules of Procedure of the General Court, Art. 156(4))
(see paragraphs 32-39)
Operative part
1.
The application for interim measures is dismissed.
2.
The costs are reserved.